-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On June 23, Shanghai Pharmaceuticals issued an announcement stating that Shanghai Shangyao Xinya Pharmaceutical Co.
Ceftriaxone sodium for injection is mainly suitable for infections caused by pathogens that are sensitive to this product, such as: sepsis; meningitis; disseminated Lyme disease (early and late); abdominal infections (peritonitis, biliary tract and Gastrointestinal infections); bone, joint, soft tissue, skin and wound infections; infections in patients with weakened immune mechanisms; kidney and urinary tract infections; respiratory tract infections, especially pneumonia, ear, nose and throat infections; reproductive system infections, including gonorrhea; preoperative Prevent infection
As of this announcement, the territory injection China for the Shanghai Roche Pharmaceutical Co.
The IQVIA database shows that the hospital procurement amount of ceftriaxone sodium for injection in 2020 is RMB 2,493.
Lansoprazole for injection is mainly used for gastric, duodenal ulcer, acute stress ulcer, and acute gastric mucosal injury that are not suitable for oral therapy.
As of this announcement, the territory of China for injection lansoprazole major manufacturers Shandong Elohim Pharmaceutical Group Co.
The IQVIA database shows that the hospital procurement amount of lansoprazole for injection in 2020 is RMB 1,766,330,000
